sr141716 has been researched along with glycine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Auclair, N; Barbara, JG; Caboche, J; Crepel, F; Otani, S; Roisin, MP; Soubrie, P; Valjent, E | 1 |
| de Novellis, V; Maione, S; Marabese, I; Mariani, L; Palazzo, E; Rossi, F; Scafuro, M; Vita, D | 1 |
| Bregestovski, P; Mukhtarov, M; Ragozzino, D | 1 |
| Lebovitz, H | 1 |
| Deadwyler, SA; Hampson, RE; Miller, F; Palchik, G | 1 |
1 review(s) available for sr141716 and glycine
| Article | Year |
|---|---|
Diabetes: assessing the pipeline.
Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin | 2006 |
5 other study(ies) available for sr141716 and glycine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex.
Topics: Animals; Anticonvulsants; Benzoxazines; Calcium Channel Blockers; Cyclopropanes; Excitatory Postsynaptic Potentials; Glycine; Immunohistochemistry; Long-Term Potentiation; Mitogen-Activated Protein Kinases; Morpholines; Naphthalenes; Neuronal Plasticity; Organ Culture Techniques; Phosphorylation; Phosphoserine; Piperidines; Prefrontal Cortex; Pyramidal Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, Metabotropic Glutamate; Rimonabant; Signal Transduction | 2003 |
Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
Topics: Action Potentials; Analgesics; Animals; Benzoates; Benzoxazines; Chromones; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Formaldehyde; Glycine; Injections, Subcutaneous; Male; Medulla Oblongata; Morpholines; Naphthalenes; Neurons; Pain Measurement; Periaqueductal Gray; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Reaction Time; Receptor, Cannabinoid, CB1; Receptors, Metabotropic Glutamate; Rimonabant | 2005 |
Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones.
Topics: Animals; Benzoxazines; Calcium; Cannabinoid Receptor Modulators; Glutamic Acid; Glycine; Hypoglossal Nerve; In Vitro Techniques; Membrane Potentials; Mice; Morpholines; Motor Neurons; N-Methylaspartate; Naphthalenes; Neural Inhibition; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cannabinoid; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Rimonabant; Synaptic Transmission | 2005 |
Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arachidonic Acids; Benzamides; Benzoxazines; Calcium; Cannabinoid Receptor Modulators; Carbamates; Endocannabinoids; Glycine; Hippocampus; In Vitro Techniques; Morpholines; Naphthalenes; Neuronal Plasticity; Neurons; Phosphorylation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Ryanodine Receptor Calcium Release Channel; Second Messenger Systems | 2011 |